Analytical Data
-
Gene name
S100A2
- Application
-
Alternative Names
S100-A2; CAN19; S100L
-
Species
Human
-
Source
E. coli
-
Tag
N- His & GST
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P29034
-
Expression Region
Met2~Pro98
-
Molecular Weight
43kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100A2 is a member of the S100 protein family, which plays critical roles in various physiological processes, including cell growth, differentiation, and apoptosis. It is a calcium-binding protein known for its involvement in intracellular signaling pathways and has been linked to several diseases, particularly cancer. Elevated levels of S100A2 have been associated with tumor progression and metastasis, making it a potential biomarker for cancer diagnosis and prognosis. Its expression is often regulated by transcription factors and can vary across different tissue types, which adds complexity to its functional roles. The study of recombinant S100A2 protein allows researchers to explore its structure-function relationship, investigate its biological activities, and develop potential therapeutic applications. Recombinant S100A2 can be produced in various expression systems, enabling the investigation of post-translational modifications and interactions with other proteins. Recent research has focused on understanding how S100A2 influences cellular processes such as migration and invasion, as well as its potential interactions with receptors and other signaling molecules. This knowledge is crucial for developing targeted therapies and improving cancer treatment strategies. Overall, the exploration of S100A2 and its recombinant forms represents a promising avenue for advancing both basic scientific understanding and clinical applications in oncology.
